DMTK DermTech
- 0.614
- -0.002-0.32%
- 0.600
- -0.014-2.26%
DermTech News
8-K: Current report
8-K: Current report
DermTech | 4: Statement of changes in beneficial ownership of securities-Officer Sun Kevin M
DermTech | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Sun Kevin M
DermTech | 4: Statement of changes in beneficial ownership of securities-Officer Akhavan Ramin
DermTech | 4: Statement of changes in beneficial ownership of securities-Officer Sun Kevin M
DermTech | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DermTech | 10-K: Annual report
DermTech | 8-K: DERMTECH REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
DermTech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(4.8%),Van Herk Investments THI B.V.(4.8%), etc.
DermTech | 8-K: Current report
DermTech | 4: Statement of changes in beneficial ownership of securities-Officer Akhavan Ramin
DermTech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
DermTech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sun Kevin M
DermTech | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Ibarra Claudia
DermTech | 4: Statement of changes in beneficial ownership of securities-General Counsel Akhavan Ramin
DermTech | 10-Q: Q3 2023 Earnings Report
DermTech | 8-K: DERMTECH REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
DermTech | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Aguillard Mark Bryan
DermTech | 3: Initial statement of beneficial ownership of securities-Chief Commercial Officer Aguillard Mark Bryan
Analysis
Price Target
No Data
